He, “Oxaliplatin Activates P53/miR‐34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells,” Immunity, Inflammation and Disease 12, no. 9 (2024): e70004, https://doi.org/10.1002/iid3.70004. Here, BIRC5 is linked to gastric cancer.